Single Cell Multiomics Market Set to Surge to $15.26 Billion by 2030, Finds Allied Market Research

WILMINGTON, DELAWARE, UNITED STATES, April 24, 2024 /EINPresswire.com/ -- The global single cell multiomics market size was valued at $2,175 million in 2020, and is projected to reach $15,261.19 million by 2030, registering a CAGR of 21.4% from 2021 to 2030. Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞: https://www.alliedmarketresearch.com/single-cell-multiomics-market-A11783

Single cell multiomics analysis assimilates multiple data sets from the genome, epigenome, transcriptome, proteome, providing a unique chance to uncover novel biological processes. Integrated approaches combine individual omics data in a sequential or simultaneous manner to understand the interplay of molecules. Furthermore, they help in assessing the flow of information from one omics level to the other, and thus help in bridging the gap from genotype to phenotype. The single cell multi omics measures multiple types of the molecule from single cell of the same individual.

The single cell sequencing technology is divided into genotypic and phenotypic, which help to determine the mechanisms to govern diseases and health. Furthermore, applications of single cell multiomics primarily include oncology, cell biology, neurology, stem cell, and immunology. Single cell omics have great potential in deciphering virus biology and virus-host cell interactions, which acts as a powerful tool in virology that should be applied more often in future.

For instance, in June 2021, BGI Americas Corporation, a part of BGI Genomics Co. Ltd. announced a collaborative agreement with Champions Oncology to offer their respective customers end-to-end proteomics and multiomics solutions for oncology biomarker discovery and validation. Thus, such collaborations among the key players significantly propels the single cell multiomics market growth.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A11783

The single cell multiomics market growth is attributed to rise in technological advancements in single-cell analysis products. Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market.

However, high cost of single cell analysis and limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Conversely, expansion into new research applications, such as single-cell metabolomics, and increase in collaborations & funding in the research of single cell multiomics are anticipated to provide lucrative growth opportunities for single cell multiomics market players.

On the basis of type, the single cell multiomics market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics and single cell metabolomics. The single cell genomics segment generated maximum revenue in 2020, accounting $897.2 million. The single cell proteomics segment is expected to witness highest CAGR of 22.3% during the forecast period.

By application, it is classified into oncology, cell biology, neurology, immunology and stem research. The oncology segment generated maximum revenue in 2020, accounting $763.17 million. The neurology segment is expected to witness highest CAGR of 24.5% during the forecast period.

Depending upon the technique, the single cell multiomics market is segmented into single-cell isolation & dispensing and single-cell analysis. The single-cell analysis segment generated maximum revenue in 2020, accounting $1,530.9 million. The single-cell isolation & dispensing segment is expected to witness highest CAGR of 22% during the forecast period.

By end user, it is further segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. The academic institutes segment generated maximum revenue in 2020, accounting $1,475.97 million. The contract research organizations segment is expected to witness highest CAGR of 22.6% during the forecast period.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A11783

Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is projected to account for a major share of $1,030.95 the global single cell multiomics market during the forecast period. The market in the region is anticipated grow in future, owing to availability of developed healthcare infrastructure and continuous research activities for the development of advanced technologies in the region. Europe holds the second largest share and is expected to witness highest CAGR of 25.2% during the forecast period.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲

Based on type, the single cell genomics segment held the largest share in the global market in 2020.

On the basis of application, the oncology held largest single cell multiomics market share in 2020 and is expected to remain dominant during the forecast period.

On the basis of technique, the single-cell analysis held largest market share in 2020 and is expected to remain dominant during the forecast period.

On the basis of end user, the academic institutes segment held largest single cell multiomics market share in 2020 and is expected to remain dominant during the forecast period.

Based on region, Europe is expected to experience growth at the highest rate, registering a CAGR of 25.2% during the forecast period.

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐎𝐟𝐟𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

𝐆𝐞𝐭 𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐢𝐛𝐫𝐚𝐫𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐚𝐭 𝐚𝐧𝐲 𝐭𝐢𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐧𝐲 𝐝𝐞𝐯𝐢𝐜𝐞 𝐚𝐧𝐝 𝐚𝐧𝐲𝐰𝐡𝐞𝐫𝐞. 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬, 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.alliedmarketresearch.com/library-access

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Single Cell Multiomics Market: https://www.alliedmarketresearch.com/single-cell-multiomics-market-A11783

Chemotherapy Induced Anemia Market: https://www.alliedmarketresearch.com/chemotherapy-induced-anemia-market-A10539

Electrophysiology Market: https://www.alliedmarketresearch.com/electrophysiology-devices-market

Mechanical Ventilator Market: https://www.alliedmarketresearch.com/mechanical-ventilators-market

𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡?
Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other